Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy
Public ClinicalTrials.gov record NCT00694382. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multinational, Randomized, Double Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of AVE5026 in the Prevention of Venous Thromboembolism (VTE) in Cancer Patients at High Risk for VTE and Who Are Undergoing Chemotherapy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective was to compare the efficacy of once daily subcutaneous injections of Semuloparin sodium (AVE5026) with placebo in the prevention of venous thromboembolism \[VTE\] in cancer patients at high risk for VTE and who were undergoing chemotherapy. The secondary objectives were to evaluate the safety of Semuloparin sodium (AVE5026), to document Semuloparin sodium (AVE5026) exposures, to try identifying a metagene predictor of VTE and to assess the survival status at one year in this population.
Study identification
- NCT ID
- NCT00694382
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 3,212 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2008 (Type not available)
- Primary completion
- Nov 2010 (Actual)
- Completion
- Nov 2010 (Actual)
- Last update posted
- Jan 23, 2013
2008 – 2010
United States locations
- U.S. sites
- 48
- U.S. states
- 20
- U.S. cities
- 46
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigational Site Number 840006 | Birmingham | Alabama | 35211 | — |
| Investigational Site Number 840007 | Casa Grande | Arizona | 85222 | — |
| Investigational Site Number 840060 | Tucson | Arizona | 85704 | — |
| Investigational Site Number 840050 | Fountain Valley | California | 92708 | — |
| Investigational Site Number 840072 | Fullerton | California | 92835 | — |
| Investigational Site Number 840037 | Indian Wells | California | 92210 | — |
| Investigational Site Number 840069 | La Verne | California | 91750 | — |
| Investigational Site Number 840009 | Long Beach | California | 90806 | — |
| Investigational Site Number 840001 | Oceanside | California | 92056 | — |
| Investigational Site Number 840011 | Rancho Mirage | California | 92270 | — |
| Investigational Site Number 840029 | West Covina | California | 91790 | — |
| Investigational Site Number 840005 | Norwich | Connecticut | 06360 | — |
| Investigational Site Number 840064 | Torrington | Connecticut | 06790 | — |
| Investigational Site Number 840038 | Woodbridge | Connecticut | 06525 | — |
| Investigational Site Number 840052 | Washington D.C. | District of Columbia | 20010 | — |
| Investigational Site Number 840025 | Washington D.C. | District of Columbia | 20017 | — |
| Investigational Site Number 840074 | Clearwater | Florida | 33756 | — |
| Investigational Site Number 840019 | Jacksonville | Florida | 32207 | — |
| Investigational Site Number 840051 | Rockledge | Florida | 32955 | — |
| Investigational Site Number 840073 | Sarasota | Florida | 34239 | — |
| Investigational Site Number 840070 | Roswell | Georgia | 30076 | — |
| Investigational Site Number 840016 | Park Ridge | Illinois | 60068 | — |
| Investigational Site Number 840028 | Quincy | Illinois | 62301 | — |
| Investigational Site Number 840008 | Skokie | Illinois | 60077 | — |
| Investigational Site Number 840033 | Goshen | Indiana | 46526 | — |
| Investigational Site Number 840010 | Indianapolis | Indiana | 46237 | — |
| Investigational Site Number 840014 | Louisville | Kentucky | 40202 | — |
| Investigational Site Number 840048 | Mount Sterling | Kentucky | 40353 | — |
| Investigational Site Number 840047 | Metairie | Louisiana | 70056 | — |
| Investigational Site Number 840032 | Ruston | Louisiana | 71270 | — |
| Investigational Site Number 840042 | Bethesda | Maryland | 20817 | — |
| Investigational Site Number 840066 | Easton | Maryland | 21601 | — |
| Investigational Site Number 840059 | Tupelo | Mississippi | 38801 | — |
| Investigational Site Number 840024 | Rochester | New York | 14642 | — |
| Investigational Site Number 840031 | Syracuse | New York | 13210 | — |
| Investigational Site Number 840020 | Durham | North Carolina | 27710 | — |
| Investigational Site Number 840021 | Durham | North Carolina | 27710 | — |
| Investigational Site Number 840026 | High Point | North Carolina | 27262 | — |
| Investigational Site Number 840046 | Bismarck | North Dakota | 58501 | — |
| Investigational Site Number 840003 | Middletown | Ohio | 45042 | — |
| Investigational Site Number 840022 | Sylvania | Ohio | 43560 | — |
| Investigational Site Number 840075 | East Providence | Rhode Island | 02915 | — |
| Investigational Site Number 840067 | Beaumont | Texas | 77701 | — |
| Investigational Site Number 840004 | El Paso | Texas | 79915 | — |
| Investigational Site Number 840034 | Houston | Texas | 77030 | — |
| Investigational Site Number 840035 | Sugar Land | Texas | 77055 | — |
| Investigational Site Number 840063 | Kennewick | Washington | 99336 | — |
| Investigational Site Number 840018 | Tacoma | Washington | 98431 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 363 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00694382, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 23, 2013 · Synced Oct 16, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00694382 live on ClinicalTrials.gov.